RETINOPATHY OF PREMATURITY (ROP)
Clinical trials for RETINOPATHY OF PREMATURITY (ROP) explained in plain language.
Never miss a new study
Get alerted when new RETINOPATHY OF PREMATURITY (ROP) trials appear
Sign up with your email to follow new studies for RETINOPATHY OF PREMATURITY (ROP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a lower dose of an eye drug protect preterm Infants' sight?
Disease control Recruiting nowThis trial investigates whether a low dose of the drug conbercept can effectively treat retinopathy of prematurity (ROP), an eye disease that can cause blindness in preterm infants. The study will enroll 146 preterm babies with type 1 ROP and compare the low-dose treatment agains…
Matched conditions: RETINOPATHY OF PREMATURITY (ROP)
Phase: NA • Sponsor: Wang Yusheng • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New drug aims to save premature babies' eyesight
Disease control Recruiting nowThis early-stage study tests a new medicine called FLQ-101 in 18 premature babies born at 26-27 weeks who are at high risk for retinopathy of prematurity (ROP), an eye disease that can cause blindness. The main goal is to check if the drug is safe and how it works in the body. Re…
Matched conditions: RETINOPATHY OF PREMATURITY (ROP)
Phase: PHASE1 • Sponsor: FELIQS INC. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
A new window into Babies' eyes: can advanced imaging improve care for premature infants?
Diagnosis Recruiting nowThis study is testing a new, noninvasive imaging device called HH-SECTR to see inside the eyes of premature infants with retinopathy of prematurity (ROP), a condition that can affect vision. The goal is to see if this technology can provide clearer, more detailed images of the re…
Matched conditions: RETINOPATHY OF PREMATURITY (ROP)
Sponsor: Vanderbilt University Medical Center • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC